Skip to Main Content

LABD  Direxion Daily S&P Biotech Bear 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Undefined
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABD

Chart for Price Movement
LABD is up 5.01% over the last 3 days.
Bid/Ask1$6.90 / $6.91
Open$6.32
Previous Close$6.25
Day Low/High
Last Price
$6.92  3% or $0.02 from its Day high
$6.23
$6.94
52 Week Range
Last Price
$6.92  1% or $0.83 from its 52 Week low
$6.09
6/26/2017
$48.74
6/27/2016
Price/Earnings--
Price/Cash Flow--
Price/Revenue--

Fund Detail

as of 5/31/2017

Profile

Profile
Total Net Assets$91.1 M
Premium/Discount0.16%
Portfolio Turnover--
Total Holdings9
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.00%
Most Recent Dividend--
Previous Pay Date--
Ex-Date--
Distribution FrequencyQuarterly
SEC Yield--

Total Returns

as of 5/31/2017

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABD Market Price
-43.95%-83.40%-------59.05%3.06%-66.78%-------48.33%-44.75%-80.31%-------52.10%
LABD NAV
-41.89%-85.35%-------59.05%3.55%-66.72%-------48.02%-44.83%-80.29%-------51.83%
Trading--Inverse Equity
Morningstar Category
------------0.26%-24.20%-16.81%-30.49%-20.82%--0.85%-14.46%-21.11%-29.79%-20.40%--
S&P 500
Index
4.46%17.81%9.80%15.24%7.25%10.62%2.57%17.47%10.14%15.42%6.94%10.60%6.07%17.17%10.37%13.30%7.51%10.59%
View Performance >

Top 5 Holdings

as of 5/31/2017
Top 5 Holdings
--Fidelity Institutional Go28.91%
--Fidelity Institutional Go17.04%
--S&P Biotechnology Select1.35%
--S&P Biotechnology Select Industry USD0.46%
Total
47.76%
More Holdings >

Top Sectors

as of 5/31/2017
Top SectorsTop Sectors
Sector% of Holdings
Basic Materials0.00%
Communication Services0.00%
Consumer Cyclical0.00%
Consumer Defensive0.00%
Total0.00%
Fund Highlights
Fund Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to an inverse fixed multiple of short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve negative 2 times the returns of a given index on a daily basis is unlikely to deliver anything like negative 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple typically negative 1 to negative 3 times the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 1.08%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.15%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window